CLINICAL TRIALS PROFILE FOR LIORESAL
✉ Email this page to a colleague
All Clinical Trials for LIORESAL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00373295 ↗ | Effect of Baclofen on Marijuana Withdrawal and Relapse | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 2006-05-01 | The purpose of this study is to determine if baclofen dose-dependently decreases marijuana's direct effects and symptoms of marijuana withdrawal and thus decreases marijuana relapse. |
NCT00373295 ↗ | Effect of Baclofen on Marijuana Withdrawal and Relapse | Completed | New York State Psychiatric Institute | Phase 2 | 2006-05-01 | The purpose of this study is to determine if baclofen dose-dependently decreases marijuana's direct effects and symptoms of marijuana withdrawal and thus decreases marijuana relapse. |
NCT00597701 ↗ | Treating Alcohol Withdrawal With Oral Baclofen | Completed | Essentia Health | N/A | 2003-04-01 | The purpose of this study is determine if subjects with alcohol withdrawal who receive oral baclofen, plus standard benzodiazepine therapy, will experience less severe withdrawal symptoms than those who receive placebo plus standard benzodiazepine therapy.Subjects with alcohol withdrawal syndrome(AWS)who receive baclofen plus standard benzodiazepine therapy will experience fewer complications of AWS (as measured by use of additional sedatives, restraints, and/or intensive care unit [ICU] admissions) compared with subjects who receive placebo plus standard benzodiazepine therapy. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LIORESAL
Condition Name
Clinical Trial Locations for LIORESAL
Trials by Country
Clinical Trial Progress for LIORESAL
Clinical Trial Phase
Clinical Trial Sponsors for LIORESAL
Sponsor Name